在患有多发性硬化症,视神经和脊髓主要受到影响的多发性硬化症患者中血清人氨酸3级的诊断价值:一项初步研究
Cem İsmail Küçükali1, Nuray Sancar1, Hande Yüceer Korkmaz1
1Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Türkiye.
Noro psikiyatri arsivi
|March 4, 2026
概括
血清人胺类3可能有助于区分神经炎光学谱障碍 (NMOSD) 与特定复发性复发性多发性硬化症 (RRMS) 病例. 在MS-SCON患者中升高的水平表明其可能被用作诊断生物标志物.
科学领域:
- 神经免疫学 神经免疫学
- 生物标志物发现发现
- 神经学 神经学
背景情况:
- 神经omyelitis光学谱系障碍 (NMOSD) 和复发性复发性多发性硬化症 (RRMS) 可以呈现重叠的临床特征,使差异诊断复杂化.
- 准确的区分对于适当的治疗和患者管理至关重要.
研究的目的:
- 调查血清人体类3 (MTRNR2L3) 水平作为潜在的诊断生物标志物,以区分NMOSD和RRMS,特别是在出现NMOSD类症状的情况下.
- 评估人体类3在确定脊髓和视神经攻击的RRMS患者 (MS-SCON) 的特定亚组中的实用性.
主要方法:
- 从30名RRMS患者,10名NMOSD患者,15名MS-SCON患者和23名健康对照患者收集了血清样本.
- 使用酶相关免疫吸收试验 (ELISA) 量化了类似人体3的水平.
- 进行了接收器操作特征 (ROC) 曲线分析以评估诊断性能.
主要成果:
- 与其他组相比,MS-SCON患者的血清人氨酸类3水平显著更高.
- 人类类3的切断值为5.26 ng/ml,在区分MS-SCON和NMOSD时显示了66.7%的灵敏度和90%的特异性.
- 在MS或NMOSD中,与人文类3水平和人口统计或临床变量之间没有发现显著的相关性.
结论:
- 血清人氨酸类3显示出作为MS患者呈现NMOSD类特征的差异诊断生物标志物的潜力.
- 在MS-SCON患者中,人体类3水平升高可能表明在这个特定的MS亚组内,神经元生存压力升高.
更多相关视频
相关概念视频
Myasthenia Gravis: Diagnostic Tests
3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K
Pneumonia III: Complications and Assessment
1.4K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
765
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495


